| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C published

Alerts

25 October, 2022 - 19:50 (CEST)

New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C.

New WHO Public Inspection Reports (WHOPIRs) published

Announcement

21 October, 2022 - 14:35 (CEST)

Newly prequalified Active Pharmaceutical Ingredient (API)

Announcement

21 October, 2022 - 14:20 (CEST)

Molnupiravir (WHOAPI-439) manufactured by Emcure Pharmaceuticals Ltd, has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) u

WHO Public Assessment Reports (WHOPARs) published

Announcement

21 October, 2022 - 12:25 (CEST)

WHO Public Assessment Reports (WHOPARs) published

Announcement

19 October, 2022 - 12:10 (CEST)

List of IVDs that were not accepted under WHO Emergency Use Listing for SARS-CoV-2

IVD

Announcement

18 October, 2022 - 21:00 (CEST)

WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated

IVD

Announcement

18 October, 2022 - 19:55 (CEST)

List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated

IVD

Announcement

18 October, 2022 - 19:50 (CEST)

WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated

IVD

Announcement

11 October, 2022 - 21:00 (CEST)

IVD newsletter, Q3 2022 - Issue 39 published

IVD

Alerts

11 October, 2022 - 18:30 (CEST)

IVD newsletter - Q

Subscribe to